- Home
- MREO vs RRBI Comparison
MREO vs RRBI Comparison
Compare MREO & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- RRBI
- Stock Information
- Founded
- MREO 2015
- RRBI 1998
- Country
- MREO United Kingdom
- RRBI United States
- Employees
- MREO N/A
- RRBI N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- RRBI Hotels/Resorts
- Sector
- MREO Health Care
- RRBI Consumer Discretionary
- Exchange
- MREO Nasdaq
- RRBI Nasdaq
- Market Cap
- MREO 424.5M
- RRBI 341.1M
- IPO Year
- MREO N/A
- RRBI 2019
- Fundamental
- Price
- MREO $2.41
- RRBI $55.13
- Analyst Decision
- MREO Strong Buy
- RRBI Buy
- Analyst Count
- MREO 7
- RRBI 1
- Target Price
- MREO $7.71
- RRBI $62.00
- AVG Volume (30 Days)
- MREO 1.5M
- RRBI 6.2K
- Earning Date
- MREO 05-19-2025
- RRBI 04-30-2025
- Dividend Yield
- MREO N/A
- RRBI 0.87%
- EPS Growth
- MREO N/A
- RRBI 13.23
- EPS
- MREO N/A
- RRBI 5.31
- Revenue
- MREO N/A
- RRBI $112,121,000.00
- Revenue This Year
- MREO N/A
- RRBI N/A
- Revenue Next Year
- MREO $56.11
- RRBI $5.90
- P/E Ratio
- MREO N/A
- RRBI $10.38
- Revenue Growth
- MREO N/A
- RRBI 6.22
- 52 Week Low
- MREO $1.58
- RRBI $42.78
- 52 Week High
- MREO $5.02
- RRBI $62.13
- Technical
- Relative Strength Index (RSI)
- MREO 50.36
- RRBI 62.54
- Support Level
- MREO $2.28
- RRBI $53.55
- Resistance Level
- MREO $2.75
- RRBI $53.00
- Average True Range (ATR)
- MREO 0.16
- RRBI 1.22
- MACD
- MREO -0.00
- RRBI 0.57
- Stochastic Oscillator
- MREO 27.66
- RRBI 90.12
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.